The U.S. Department of Health and Human Services' Administration for Strategic Preparedness and Response (ASPR) recently confirmed it is making a total of 1.1 million vials of Bavarian Nordic's Jynneos® vaccine available to jurisdictions in the USA to support monkeypox response efforts.
As of September 14, 2022, ASPR had released 807,093 vials to all jurisdictions for free.
These Jynneos vaccines support the 23,893 confirmed monkeypox/orthopoxvirus cases in the USA as of September 19, 2022.
Who Says Staff Doesn't Need Monkeypox Vaccinations
Bebtelovimab Appears Reliable for COVID-19 During Omicron Epoch
Patients receiving bebtelovimab have more comorbidities, but do not have increased rates of progression to severe disease